These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 539420)
21. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca]. Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414 [TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Mossong J; Putz L; Schneider F Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584 [TBL] [Abstract][Full Text] [Related]
23. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. Jablonka A; Happle C; Grote U; Schleenvoigt BT; Hampel A; Dopfer C; Hansen G; Schmidt RE; Behrens GM Infection; 2016 Dec; 44(6):781-787. PubMed ID: 27449329 [TBL] [Abstract][Full Text] [Related]
24. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Ahlgren C; Odén A; Torén K; Andersen O Acta Neurol Scand; 2009 May; 119(5):313-20. PubMed ID: 19154535 [TBL] [Abstract][Full Text] [Related]
25. A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls. Haile R; Smith P; Read D; Nassim D; Warlow C; Russell WC J Neurol Sci; 1982 Oct; 56(1):1-10. PubMed ID: 7143023 [TBL] [Abstract][Full Text] [Related]
26. [Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life]. Devecioğlu E; Gökçay G; Boran P; Eren T; Yılmaz G; Badur S Mikrobiyol Bul; 2018 Jul; 52(3):324-327. PubMed ID: 30156519 [TBL] [Abstract][Full Text] [Related]
27. [Relation between serologic verification and anamnestic data on the principal virus diseases of infancy]. Profeta ML; Ferrante P; Mendogni D Boll Ist Sieroter Milan; 1987; 66(5):367-76. PubMed ID: 3449098 [TBL] [Abstract][Full Text] [Related]
28. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme. Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C Microbios; 1996; 88(356):143-8. PubMed ID: 9141711 [TBL] [Abstract][Full Text] [Related]
29. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization? Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745 [TBL] [Abstract][Full Text] [Related]
30. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers]. Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214 [TBL] [Abstract][Full Text] [Related]
31. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age. Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613 [TBL] [Abstract][Full Text] [Related]
33. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Bernstein CN; Rawsthorne P; Blanchard JF Inflamm Bowel Dis; 2007 Jun; 13(6):759-62. PubMed ID: 17230540 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods. Cremer NE; Johnson KP; Fein G; Likosky WH Arch Neurol; 1980 Oct; 37(10):610-5. PubMed ID: 6252874 [TBL] [Abstract][Full Text] [Related]
35. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374 [TBL] [Abstract][Full Text] [Related]
36. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Amela C; Pachón I; de Ory F Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626 [TBL] [Abstract][Full Text] [Related]
39. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Ramondetti F; Sacco S; Comelli M; Bruno G; Falorni A; Iannilli A; d'Annunzio G; Iafusco D; Songini M; Toni S; Cherubini V; Carle F; Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003 [TBL] [Abstract][Full Text] [Related]
40. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. Anderson RM; May RM J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]